New technology to detect cancer licenced

May 17, 2005

Oncomethylome Sciences licences technology developed at the Max Planck Institute of Biochemistry in Martinsried, Germany, for detecting novel methylated genes in prostate cancer.

Oncomethylome Sciences licences technology developed at the Max Planck Institute of Biochemistry in Martinsried, Germany, for detecting novel methylated genes in prostate cancer.

Web-View
Print Page
Open in new window
Estimated DIN-A4 page-width
Go to Editor View